Trials / Terminated
TerminatedNCT04540874
A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 894416 Versus Placebo in Healthy Male Japanese Subjects (Single-blind, Randomized, Placebo-controlled Within Dose Group)
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this trial is to investigate the safety, tolerability and pharmacokinetics of BI 894416 in healthy Japanese male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 894416 | BI 894416 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2020-10-05
- Primary completion
- 2020-11-12
- Completion
- 2020-11-12
- First posted
- 2020-09-07
- Last updated
- 2023-08-16
- Results posted
- 2023-08-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04540874. Inclusion in this directory is not an endorsement.